Alnylam Pharmaceuticals, Inc. (ETR:DUL)
Germany · Delayed Price · Currency is EUR 384.30
-3.10 (-0.80%)
Nov 17, 2025, 7:30 AM CET
Alnylam Pharmaceuticals Market Cap
Alnylam Pharmaceuticals has a market cap or net worth of €51.08 billion as of November 14, 2025. Its market cap has increased by 53.51% in one year.
Market Cap
51.08B
Enterprise Value
51.12B
Revenue
2.74B
Ranking
n/a
PE Ratio
1,375.69
Stock Price
€384.30
Market Cap Chart
Since May 28, 2004, Alnylam Pharmaceuticals's market cap has increased from 94.86M to 51.08B, an increase of 53,748.84%. That is a compound annual growth rate of 34.01%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 14, 2025 | 51.08B | 74.24% |
| Dec 31, 2024 | 29.32B | 34.90% |
| Dec 29, 2023 | 21.73B | -20.57% |
| Dec 30, 2022 | 27.36B | 53.40% |
| Dec 31, 2021 | 17.83B | 44.47% |
| Dec 31, 2020 | 12.34B | 7.89% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Merck KGaA | 51.11B |
| Siemens Healthineers AG | 48.78B |
| Bayer Aktiengesellschaft | 27.91B |
| Fresenius SE & Co. KGaA | 27.44B |
| Sartorius Aktiengesellschaft | 14.22B |
| Fresenius Medical Care AG | 11.67B |
| Carl Zeiss Meditec AG | 3.74B |
| Fielmann Group AG | 3.68B |